These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12894101)

  • 1. Etanercept and squamous cell carcinoma.
    Burge D
    J Am Acad Dermatol; 2003 Aug; 49(2):358-9; author reply 359. PubMed ID: 12894101
    [No Abstract]   [Full Text] [Related]  

  • 2. The rapid onset of multiple squamous cell carcinomas during etanercept treatment for psoriasis.
    Ly L; Czarnecki D
    Br J Dermatol; 2007 Nov; 157(5):1076-8. PubMed ID: 17854370
    [No Abstract]   [Full Text] [Related]  

  • 3. Foot ulcers caused by rheumatoid vasculitis in a patient with rheumatoid arthritis undergoing etanercept treatment.
    Murosaki T; Nagashima T; Aoki Y; Imai Y; Iwamoto M; Minota S
    Intern Med; 2012; 51(22):3181-3. PubMed ID: 23154729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Etanercept Treatment for Primary Biliary Cirrhosis Associated with Rheumatoid Arthritis.
    Kovács A; Siminischi AG; Baksay B; Gáll A; Takács M; Szekanecz Z
    Isr Med Assoc J; 2015 Feb; 17(2):114-6. PubMed ID: 26223090
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
    Koens L; Senff NJ; Vermeer MH; Ronday HK; Willemze R; Jansen PM
    Acta Derm Venereol; 2009 Nov; 89(6):653-4. PubMed ID: 19997706
    [No Abstract]   [Full Text] [Related]  

  • 6. No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years.
    Lebwohl M; Blum R; Berkowitz E; Kim D; Zitnik R; Osteen C; Wallis WJ
    Arch Dermatol; 2005 Jul; 141(7):861-4. PubMed ID: 16027301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphopenia induced by etanercept.
    Pepper AN; Talreja N; Cowan GM; Glaum MC; Lockey RF
    Ann Allergy Asthma Immunol; 2014 Mar; 112(3):262-3. PubMed ID: 24565596
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis.
    Yamamoto M; Takahashi H; Wakasugi H; Sukawa Y; Saito M; Suzuki C; Naishiro Y; Yamamoto H; Shinomura Y; Imai K
    Mod Rheumatol; 2007; 17(1):72-4. PubMed ID: 17278027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lung carcinoma in a patient with rheumatoid arthritis treated with tumor necrosis factor antagonist].
    Okubo T; Kawada M; Suzuki Y; Kawarada Y; Kitashiro S; Okushiba S
    Kyobu Geka; 2012 Dec; 65(13):1147-9. PubMed ID: 23202712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept treatment in patients with rheumatoid arthritis on dialysis.
    Nakamura T; Higashi S; Tomoda K; Tsukano M; Arizono K; Nakamura T
    Rheumatol Int; 2010 Sep; 30(11):1527-8. PubMed ID: 20358202
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
    Asahina A; Ishii N; Tohma S
    J Dermatol; 2012 Feb; 39(2):199-201. PubMed ID: 21463364
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor alpha receptor IgG1-Fc fusion complex therapy.
    Smith KJ; Skelton HG
    J Am Acad Dermatol; 2001 Dec; 45(6):953-6. PubMed ID: 11712048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept-Induced Pneumonitis: Severe Complication of Tumor Necrosis Factor-Alpha Blocker Treatment.
    Watad A; Perelman M; Mansour R; Shoenfeld Y; Amital H
    Isr Med Assoc J; 2015 Feb; 17(2):130-2. PubMed ID: 26223096
    [No Abstract]   [Full Text] [Related]  

  • 14. Oropharyngeal carcinoma arising after methotrexate and etanercept therapy for rheumatoid arthritis.
    Chainani-Wu N; Chang C; Gross AJ; Yom SS; Silverman S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):e261-3. PubMed ID: 24528797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
    Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V
    CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraplegia in a patient receiving anti-tumor necrosis factor therapy for rheumatoid arthritis: comment on the article by Mohan et al.
    van der Laken CJ; Lems WF; van Soesbergen RM; van der Sande JJ; Dijkmans BA
    Arthritis Rheum; 2003 Jan; 48(1):269-70. PubMed ID: 12528130
    [No Abstract]   [Full Text] [Related]  

  • 17. Etanercept treatment of rheumatoid arthritis in the "real world".
    Smith MD
    Ann Rheum Dis; 2003 Jan; 62(1):95-6; author reply 96. PubMed ID: 12480688
    [No Abstract]   [Full Text] [Related]  

  • 18. Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?
    Nagashima T; Minota S
    Clin Rheumatol; 2010 Jul; 29(7):819-20. PubMed ID: 20405301
    [No Abstract]   [Full Text] [Related]  

  • 19. Rheumatoid arthritis, TNF inhibitors, and non-melanoma skin cancer.
    Assassi S
    BMJ; 2016 Jan; 352():i472. PubMed ID: 26822198
    [No Abstract]   [Full Text] [Related]  

  • 20. Cautionary note: a possible association between oral squamous cell carcinoma and tumor necrosis factor antagonists; need for oral screening.
    Rahman N; Healy C; Flint SR; Stassen LF
    J Clin Rheumatol; 2010 Jun; 16(4):197-9. PubMed ID: 20511984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.